UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex

PloS one, 2015-08, Vol.10 (8), p.e0135025-e0135025

2015

Link zum Volltext

Verfügbarkeit prüfen

Sphingolipids as Bioactive Regulators of Thrombin Generation

The Journal of biological chemistry, 2004-03, Vol.279 (13), p.12036-12042

2004

Link zum Volltext

Verfügbarkeit prüfen

Characterization of a Factor Xa Binding Site on Factor Va near the Arg-506 Activated Protein C Cleavage Site

The Journal of biological chemistry, 2007-07, Vol.282 (30), p.21848-21855

2007

Link zum Volltext

Verfügbarkeit prüfen

Raising the Active Site of Factor VIIa above the Membrane Surface Reduces Its Procoagulant Activity but Not Factor VII Autoactivation

The Journal of biological chemistry, 2006-09, Vol.281 (36), p.26062-26068

2006

Link zum Volltext

Verfügbarkeit prüfen

Identification of Distinct Sequences in Human Blood Coagulation Factor Xa and Prothrombin Essential for Substrate and Cofactor Recognition in the Prothrombinase Complex

The Journal of biological chemistry, 2003-08, Vol.278 (35), p.33312-33318

2003

Link zum Volltext

Verfügbarkeit prüfen

Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C

Thrombosis and haemostasis, 2009-01, Vol.101 (1), p.55

2009

Link zum Volltext

Verfügbarkeit prüfen

Bisaryl Hydrazones as Exchangeable Biocompatible Linkers

Angewandte Chemie (International ed.), 2010-03, Vol.49 (11), p.2023-2027

2010

Link zum Volltext

Verfügbarkeit prüfen

Glucosylceramide, a Neutral Glycosphingolipid Anticoagulant Cofactor, Enhances the Interaction of Human- and Bovine-activated Protein C with Negatively Charged Phospholipid Vesicles

The Journal of biological chemistry, 2003-04, Vol.278 (17), p.14614-14621

2003

Link zum Volltext

Verfügbarkeit prüfen

Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data

Blood, 2015-09, Vol.126 (13), p.1595-1600

2015

Link zum Volltext

Verfügbarkeit prüfen

Activated protein C variants with normal cytoprotective but reduced anticoagulant activity

Blood, 2004-09, Vol.104 (6), p.1740-1744

2004

Link zum Volltext

Verfügbarkeit prüfen

Caractérisation in vitro des concentrés plaquettaires traités par INTERCEPT et conservés pendant 7 jours

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine, 2018-11, Vol.25 (4), p.341-342

2018

Link zum Volltext

Verfügbarkeit prüfen

Site-Directed Pegylation of BDD FVIII (BAY 94-9027) Does Not Alter the Ability of the Molecule to Generate Thrombin, Activate Factor X or Become Inactivated By Activated Protein C

Blood, 2014-12, Vol.124 (21), p.1492-1492

2014

Link zum Volltext

Verfügbarkeit prüfen

Bisarylhydrazones as Exchangeable Biocompatible Linkers

Angewandte Chemie (International ed.), 2010-03, Vol.49 (11), p.2023-2027

2010

Link zum Volltext

Verfügbarkeit prüfen

Targeted Inhibition of Activated Protein C Anticoagulant Activity By Monoclonal Antibody HAPC1573 for Treatment of Hemophilia

Blood, 2016-12, Vol.128 (22), p.80-80

2016

Link zum Volltext

Verfügbarkeit prüfen

Acylcarnitines Are Novel Anticoagulant Lipids That Target Factor Xa and That Are Reduced in Plasma of Venous Thrombosis Patients Based on Untargeted and Targeted Metabolomics

Blood, 2014-12, Vol.124 (21), p.2797-2797

2014

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulant dysfunction of human Arg352Trp-activated protein C caused by defective factor Va inactivation

Thrombosis and haemostasis, 2001-02, Vol.85 (2), p.274

2001

Link zum Volltext

Verfügbarkeit prüfen

Plasma High Density Lipoprotein and Anticoagulant Response to Activated Protein C (APC) and Protein S

Blood, 2011-11, Vol.118 (21), p.2249-2249

2011

Link zum Volltext

Verfügbarkeit prüfen

Infrared fluorescence for vascular barrier breach in vivo--a novel method for quantitation of albumin efflux

Thrombosis and haemostasis, 2012-11, Vol.108 (5), p.981

2012

Link zum Volltext

Verfügbarkeit prüfen

Lyso-Sulfatide Binds Factor Xa and Potently Inhibits Thrombin Generation

Blood, 2010-11, Vol.116 (21), p.1130-1130

2010

Link zum Volltext

Verfügbarkeit prüfen

Bisaryl Hydrazones as Exchangeable Biocompatible Linkers

Angewandte Chemie, 2010-03, Vol.122 (11), p.2067-2071

2010

Link zum Volltext

Verfügbarkeit prüfen

The Thrombin-sensitive Region of Protein S Mediates Phospholipid-dependent Interaction with Factor XaS

The Journal of biological chemistry, 2008-11, Vol.283 (48), p.33046-33052

2008

Link zum Volltext

Verfügbarkeit prüfen

Relocating the Active Site of Activated Protein C Eliminates the Need for Its Protein S Cofactor

The Journal of biological chemistry, 1999-02, Vol.274 (9), p.5462-5468

1999

Link zum Volltext

Verfügbarkeit prüfen

FRET studies with factor X mutants provide insight into the topography of the membrane-bound factor X/Xa

Biochemical journal, 2007-11, Vol.407 (3), p.427-433

2007

Link zum Volltext

Verfügbarkeit prüfen

Protein S Alters the Active Site Location of Activated Protein C above the Membrane Surface

The Journal of biological chemistry, 1997-10, Vol.272 (40), p.25013-25021

1997

Link zum Volltext

Verfügbarkeit prüfen

Manipulation of thrombin exosite I, by ligand‐directed covalent modification

Journal of thrombosis and haemostasis, 2007-10, Vol.5 (10), p.2062-2069

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(37)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex

Sphingolipids as Bioactive Regulators of Thrombin Generation

Characterization of a Factor Xa Binding Site on Factor Va near the Arg-506 Activated Protein C Cleavage Site

Raising the Active Site of Factor VIIa above the Membrane Surface Reduces Its Procoagulant Activity but Not Factor VII Autoactivation

Identification of Distinct Sequences in Human Blood Coagulation Factor Xa and Prothrombin Essential for Substrate and Cofactor Recognition in the Prothrombinase Complex

Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C

Bisaryl Hydrazones as Exchangeable Biocompatible Linkers

Glucosylceramide, a Neutral Glycosphingolipid Anticoagulant Cofactor, Enhances the Interaction of Human- and Bovine-activated Protein C with Negatively Charged Phospholipid Vesicles

Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data

Activated protein C variants with normal cytoprotective but reduced anticoagulant activity

Caractérisation in vitro des concentrés plaquettaires traités par INTERCEPT et conservés pendant 7 jours

Site-Directed Pegylation of BDD FVIII (BAY 94-9027) Does Not Alter the Ability of the Molecule to Generate Thrombin, Activate Factor X or Become Inactivated By Activated Protein C

Bisarylhydrazones as Exchangeable Biocompatible Linkers

Targeted Inhibition of Activated Protein C Anticoagulant Activity By Monoclonal Antibody HAPC1573 for Treatment of Hemophilia

Acylcarnitines Are Novel Anticoagulant Lipids That Target Factor Xa and That Are Reduced in Plasma of Venous Thrombosis Patients Based on Untargeted and Targeted Metabolomics

Anticoagulant dysfunction of human Arg352Trp-activated protein C caused by defective factor Va inactivation

Plasma High Density Lipoprotein and Anticoagulant Response to Activated Protein C (APC) and Protein S

Infrared fluorescence for vascular barrier breach in vivo--a novel method for quantitation of albumin efflux

Lyso-Sulfatide Binds Factor Xa and Potently Inhibits Thrombin Generation

Bisaryl Hydrazones as Exchangeable Biocompatible Linkers

The Thrombin-sensitive Region of Protein S Mediates Phospholipid-dependent Interaction with Factor XaS

Relocating the Active Site of Activated Protein C Eliminates the Need for Its Protein S Cofactor

FRET studies with factor X mutants provide insight into the topography of the membrane-bound factor X/Xa

Protein S Alters the Active Site Location of Activated Protein C above the Membrane Surface

Manipulation of thrombin exosite I, by ligand‐directed covalent modification

Suchergebnisse filtern